Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity

Blood Cancer Journal, Published online: 06 February 2024; doi:10.1038/s41408-024-00988-xEfficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity

Source: Blood Cancer Journal - February 6, 2024 Category: Hematology Authors: Ioannis V. Kostopoulos Despina Fotiou Maria Gavriatopoulou Pantelis Rousakis Ioannis Ntanasis-Stathopoulos Chrysanthi Panteli Panagiotis Malandrakis Magdalini Migkou Nikolaos Angelis Nikolaos Kanellias Evangelos Eleutherakis-Papaiakovou Foteini Theodoraka Source Type: research